| Greece | | |
Time spent for sleeping (men and women, minutes per day per person) | 500.0 (2013) [21/30countries] | | | Time spent for sleeping (men, minutes per day per person) | 501.4 (2013) [18/30countries] | | | Time spent for sleeping (women, minutes per day per person) | 498.0 (2013) [26/30countries] | | |
|
| Greece | | |
Time spent for eating and drinking (men and women, minutes per day per person) | 127.5 (2013) [2/30countries] | | | Time spent for eating and drinking (men, minutes per day per person) | 134.4 (2013) [1/30countries] | | | Time spent for eating and drinking (women, minutes per day per person) | 121.5 (2013) [4/30countries] | | |
|
| Greece | | |
Age-standardized prevalence of tobacco use among persons 15 years and olders (%) | 33.5% (2020) [2/38countries] | | |
|
| Greece | | |
% of those who think that the spread of infectious diseases is a major threat to their country | 80.3% (2022) [2/17countries] | | | New HIV infections (per 1000 uninfected population) | 0.09 (2020) [6/19countries] | | | Tuberculosis incidence (per 100,000 population) | 4.1 (2021) [28/38countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 0.1 (2020) [19/38countries] | | | Reported number of people requiring interventions against NTDs | 24 (2021) [8/34countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 12.5 (2019) [11/38countries] | | |
|
| Greece | | |
% of those who think that their life has changed as a result of the coronavirus outbreak | 83.7% (2021) [2/15countries] | | | % of those who think that their country is now more united than before the coronavirus outbreak | 28.6% (2022) [11/17countries] | | | % of those who think that getting a Covid-19 vaccine is very important to be a good citizen | 53.3% (2022) [11/17countries] | | | % of those who think that their country has done a good job dealing with the coronavirus outbreak | 61.6% (2022) [13/17countries] | | | % of those who think that there should have been more restrictions during the coronavirus outbreak in their country | 66.8% (2021) [3/15countries] | | | % of those who think that there should have been fewer restrictions during the coronavirus outbreak in their country | 44.0% (2021) [1/15countries] | | | % of those who think that their country handles the coronavirus outbreak in ways that show the strengths of the political system | 40.0% (2022) [16/17countries] | | | % of those who think that their country's economy recovers from the coronavirus outbreak in ways that show the strengths of the economic system | 29.3% (2021) [11/15countries] | | | % of those who think that the US has done a good job dealing with the coronavirus outbreak | 45.8% (2021) [4/15countries] | | | % of those who think that China has done a good job dealing with the coronavirus outbreak | 76.2% (2021) [1/15countries] | | | % of those who think that Germany has done a good job dealing with the coronavirus outbreak | 59.5% (2021) [12/14countries] | | | % of those who think that the EU has done a good job dealing with the coronavirus outbreak | 54.3% (2021) [8/15countries] | | | % of those who think that the WHO has done a good job dealing with the coronavirus outbreak | 64.3% (2021) [6/15countries] | | |
|
| Greece | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 264.7 (2020) [29/38countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 21.2 (2020) [1/38countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 7.0 (2020) [4/38countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 71.9 (2020) [24/38countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 8.0 (2020) [21/38countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 75.7 (2020) [15/38countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 19.2 (2020) [7/38countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.2 (2020) [38/38countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 7.8 (2020) [25/38countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 3.5 (2020) [5/38countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 8.6 (2020) [11/38countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 2.4 (2020) [30/38countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 6.6 (2020) [6/38countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 34.9 (2020) [6/38countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 11.5 (2020) [32/38countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 3.2 (2020) [20/38countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 1.0 (2020) [2/37countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 10.6 (2020) [22/38countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 1.0 (2020) [35/38countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.4 (2020) [34/38countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 9.2 (2020) [10/38countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 8.1 (2020) [18/38countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 48.2 (2020) [34/38countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 6.1 (2020) [19/38countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 6.4 (2020) [23/38countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 8.5 (2020) [20/38countries] | | |
|
| Greece | | |
Suicide, age-standardized (per 100 000 population) | 3.62 (2019) [37/38countries] | | | Suicide - male, age-standardized (per 100 000 population) | 5.90 (2019) [37/38countries] | | | Suicide - female, age-standardized (per 100 000 population) | 1.45 (2019) [37/38countries] | | | Suicide - 15-24 years (per 100,000 population) | 2.10 (2019) [38/38countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 3.33 (2019) [37/38countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 0.81 (2019) [38/38countries] | | | Suicide - 25-34 years (per 100,000 population) | 3.27 (2019) [37/38countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 4.70 (2019) [37/38countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 1.73 (2019) [35/38countries] | | | Suicide - 35-44 years (per 100,000 population) | 4.57 (2019) [36/38countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 6.71 (2019) [36/38countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 2.36 (2019) [34/38countries] | | | Suicide - 45-54 years (per 100,000 population) | 7.82 (2019) [33/38countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 13.02 (2019) [34/38countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 2.72 (2019) [34/38countries] | | | Suicide - 55-64 years (per 100,000 population) | 8.07 (2019) [35/38countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 13.59 (2019) [34/38countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 3.03 (2019) [33/38countries] | | | Suicide - 65-74 years (per 100,000 population) | 6.68 (2019) [34/38countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 11.52 (2019) [34/38countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 2.50 (2019) [34/38countries] | | | Suicide - 75-84 years (per 100,000 population) | 7.40 (2019) [33/38countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 15.32 (2019) [32/38countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 1.34 (2019) [35/38countries] | | | Suicide - 85 years and over (per 100,000 population) | 7.58 (2019) [34/38countries] | | |
|
| Greece | | |
Density of medical doctors (per 10,000 population) | 63.1 (2013?2021) [2/38countries] | | | Density of nursing and midwifery personnel (per 10,000 population) | 37.0 (2013?2021) [34/38countries] | | | Density of dentists (per 10,000 population) | 13.0 (2013?2021) [4/38countries] | | | Density of pharmacists (per 10,000 population) | 10.9 (2013?2021) [10/37countries] | | | Hospital beds (number per 1,000 population) | 4.2 (2018) [17/38countries] | | | Health expenditure (% of GDP) | 8.6% (2022) [24/38countries] | | | Population with household expenditures on health > 10% of total household expenditure or income (%) | 16.9 (2013?2021) [2/23countries] | | | % of those who have confidence in their country's healthcare system to handle a future global health emergency | 59.7% (2021) [14/15countries] | | | % of those who think that their country's healthcare system needs major reform | 77.6% (2021) [1/15countries] | | |
|
|